Abstract:Herpes simplex virus 1 (HSV-1) is a neurotropic virus that can undergo both productive and latent infection in neurons. ICP0 is an HSV-1 E3 ubiquitin ligase crucial for productive infection and reactivation from latency. However, its targets have not been systematically investigated in neuronal cells. After confirming the importance of ICP0 in HSV-1 neuronal replication using an ICP0-null virus, we identified many ICP0-interacting proteins in infected neuronal and non-neuronal cells by mass-spectrometry-based interactome analysis. Co-immunoprecipitation assays validated ICP0 interactions with ACOT8, C1QBP, OTUD4, SNX9 and VIM in both Neuro-2a and 293T cells. Overexpression and knockdown experiments showed that SNX9 restricted replication of the ICP0-null but not wild-type virus in Neuro-2a cells. Ubiquitinome analysis by immunoprecipitating the trypsin digested ubiquitin reminant followed by mass spectrometry identified numerous candidate ubiquitination substrates of ICP0 in infected Neuro-2a cells, among which OTUD4 and VIM were novel substrates confirmed to be ubiquitinated by transfected ICP0 in Neuro-2a cells despite no evidence of their degradation by ICP0. Expression of OTUD4 was induced independently of ICP0 during HSV-1 infection. Overexpressed OTUD4 enhanced type I interferon expression during infection with the ICP0-null but not wild-type virus. In summary, by combining two proteomic approaches followed by confirmatory and functional experiments, we identified and validated multiple novel targets of ICP0 in neuronal cells, and revealed potential restrictive activities of SNX9 and OTUD4 as well as ICP0-dependent antagonism of these activities. Author Summary Herpes simplex virus 1 (HSV-1) establishes latent infection in neurons. ICP0 is known for its critical role in antagonizing cellular restrictive functions thereby initiating productive infection. It has been demonstrated to be important for both acute infection and reactivation from latency in neurons. However, little is known about its targets in neuronal cells. Here we combined two proteomic approaches, interactome and ubiquitinome analyses, to integratively identify interaction partners and substrates of ICP0 in HSV-1 infected neuronal cells. The results identified many novel targets as well as confirming previously reported ones. We also further validated some of the binding interactions and ubiquitin modifications. Functional studies revealed that the ICP0-interacting protein SNX9 restricted HSV-1 replication and the ICP0 substrate OTUD4 was induced to enhance type I interferon expression during HSV-1 neuronal infection. Moreover, the activities of these proteins appeared to be antagonized by ICP0-dependent mechanisms. This study provided comprehensive insight into ICP0 targets in neuronal cells and might prompt further investigation into the newly identified targets of ICP0. ### Competing Interest Statement The authors have declared no competing interest.

A Subcellular Quantitative Proteomic Analysis of Herpes Simplex Virus Type 1-Infected HEK 293T Cells

Prediction and Analysis of Human-Herpes Simplex Virus Type 1 Protein-Protein Interactions by Integrating Multiple Methods

[Mechanisms of Herpes Simplex Virus Latency and Reactivation].

Regulation of Host and Virus Genes by Neuronal Mir-138 Favours Herpes Simplex Virus 1 Latency.

Integrative Interactome and Ubiquitinome Analyses Reveal Multiple Regulatory Pathways Targeted by ICP0 in HSV-1 Infected Neuronal Cells

A Herpesviral Lytic Protein Regulates the Structure of Latent Viral Chromatin

Quantitative Proteomic Analysis of Human Corneal Epithelial Cells Infected with HSV-1.

Regulation of T Cell Activation by Herpes Simplex Virus 1 Protein Us3

Characterization of the subcellular localization of herpes simplex virus type 1 proteins in living cells

Herpes Simplex Virus 1 Γ 1 34.5 Protein Inhibits STING Activation That Restricts Viral Replication

Subcellular Quantitative Proteomic Analysis Reveals Host Proteins Involved in Human Cytomegalovirus Infection.

Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0

Characterization of the Immunologic Phenotype of Dendritic Cells Infected With Herpes Simplex Virus 1

Immunological Identification and Characterization of the Capsid Scaffold Protein Encoded by UL26.5 of Herpes Simplex Virus Type 2

Novel transcription regulatory sequences and factors of the immune evasion protein ICP47 (US12) of herpes simplex viruses

Prediction and Identification of Herpes Simplex Virus 1-Encoded Micrornas

Herpes Simplex Virus-1 targets the 2’-3’cGAMP importer SLC19A1 as an antiviral countermeasure

Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates Cgas/sting-Mediated Antiviral Innate Immunity

T Cell Receptor Signaling Pathways： New Targets for Herpes Simplex Virus

iTRAQ-based proteomics analysis of HCMV latency and reactivation in T98G cells

Insights on the Cgas-Sting Signaling Pathway During Herpesvirus Infections